AAC Holdings Inc (AAC) was Upgraded by Raymond James to ” Strong Buy”. Earlier the firm had a rating of “Outperform ” on the company shares. Raymond James advised their investors in a research report released on Aug 15, 2016.
Many Wall Street Analysts have commented on AAC Holdings Inc. Company shares were Reiterated by Mizuho on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 26 from a previous price target of $24 .Mizuho Upgraded AAC Holdings Inc on May 25, 2016 to ” Buy”, Price Target of the shares are set at $24.
On the company’s financial health, AAC Holdings Inc reported $0.18 EPS for the quarter, missing the analyst consensus estimate by $ -0.05 based on the information available during the earnings call on Aug 4, 2016. Analyst had a consensus of $0.23. The company had revenue of $71.50 million for the quarter, compared to analysts expectations of $67.41 million. The company’s revenue was up 32.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.26 EPS.
AAC Holdings Inc closed down -0.1 points or -0.57% at $17.35 with 85,558 shares getting traded on Friday. Post opening the session at $17.4, the shares hit an intraday low of $17.05 and an intraday high of $17.56 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Jul 29, 2016, Michael T. Cartwright (Chairman and CEO) sold 24,576 shares at $23.26 per share price. According to the SEC, on Jul 5, 2016, Kathryn Sevier Phillips (General Counsel and Secretary) sold 3,500 shares at $23.00 per share price. On Jul 5, 2016, Kirk R. Manz (Chief Financial Officer) sold 7,300 shares at $22.52 per share price, according to the Form-4 filing with the securities and exchange commission.
AAC Holdings Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company operates approximately seven residential substance abuse treatment facilities and one outpatient substance abuse treatment facility. Its substance abuse treatment facilities are located throughout the United States focused on delivering clinical care and treatment solutions across its approximately 560 beds which includes approximately 378 licensed detoxification beds. It has made investments in its treatment facilities. The Company provides care to adults and adolescents struggling with alcohol and/or drug abuse and dependence as well as co-occurring mental health issues. The Company offers various treatment services which include detoxification residential treatment partial hospitalization and intensive outpatient services.